Skip to main content
Celltrion Pharm Inc. logo

Celltrion Pharm Inc. — Investor Relations & Filings

Ticker · 068760 ISIN · KR7068760008 KO Manufacturing
Open in API
Filings indexed 336 across all filing types
Latest filing 2023-03-03 Proxy Solicitation & In…
Country KR South Korea
Listing KO 068760

About Celltrion Pharm Inc.

https://www.celltrionph.com/en-us/home/…

Celltrion Pharm Inc. is a pharmaceutical company specializing in the manufacturing and supply of chemical pharmaceuticals and biosimilar products. The company's portfolio includes treatments for various conditions, with a notable focus on biosimilars for autoimmune diseases. A key product is Remsima, a biosimilar of Infliximab, indicated for treating rheumatoid arthritis, Crohn's disease, ulcerative colitis, and psoriasis. As an integral part of the global biopharmaceutical company Celltrion, Celltrion Pharm distributes its products to both domestic and international markets, contributing to the accessibility of advanced biologic therapies.

Recent filings

Filing Released Lang Actions
주주총회소집결의
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a formal notice of a General Meeting of Shareholders (주주총회소집결의) for Celltrion Pharm. It outlines the date, location, and specific agenda items (financial statement approval, director appointments, etc.) for the upcoming Annual General Meeting. This type of document is a standard proxy solicitation and information statement provided to shareholders to inform them of the meeting and request their participation/votes.
2023-03-03 Korean
대규모기업집단현황공시[분기별공시(개별회사용)]
Audit Report / Information Classification · 95% confidence The document is a 'Corporate Group Status Disclosure' (기업집단현황공시) filed by Celltrion Pharm. This is a mandatory regulatory filing in South Korea required by the Fair Trade Commission to disclose information about large business groups, including shareholding structures, inter-company transactions, and debt guarantees. Since it is a specific regulatory disclosure document that does not fit into categories like financial reports (10-K/IR) or earnings releases, it falls under the 'Regulatory Filings' (RNS) category. Q2 2024
2023-02-28 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is titled '임원ㆍ주요주주 특정증권등 소유상황보고서' (Report on Ownership of Specific Securities by Executives and Major Shareholders). It details the share ownership changes of an executive (Choi Seung-jae) at Celltrion Pharm. This is a standard regulatory filing for insider trading/director dealings, which corresponds to the 'Director's Dealing' category.
2023-02-07 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Korean Financial Supervisory Service. It details the sale of shares by an executive (Jeon Yu-jin) of Celltrion Pharm. This type of filing, which reports personal share transactions by company insiders, is classified as 'Director's Dealing' (DIRS).
2023-01-02 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Korean Financial Supervisory Service. This type of filing is specifically used to report insider transactions or changes in share ownership by company directors and executives. Based on the provided definitions, this falls under 'Director's Dealing' (DIRS).
2023-01-02 Korean
배당락(주식배당)
Notice of Dividend Amount Classification · 100% confidence The document is a short, structured announcement regarding '배당락' (ex-dividend date) for Celltrion Pharm. It specifies the ex-dividend date, the reason (stock dividend), and the reference price. Since it is a specific announcement regarding dividend mechanics rather than a general dividend payment notice or a full financial report, it fits the criteria for a regulatory announcement regarding corporate actions.
2022-12-27 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.